Kadcyla and Eczema exacerbated - a phase IV clinical study of FDA data

Summary:

Eczema exacerbated is reported as a side effect among people who take Kadcyla (ado-trastuzumab emtansine), especially for people who are female, 30-39 old, have been taking the drug for 6 - 12 months also take Perjeta, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Eczema exacerbated when taking Kadcyla. It is created by eHealthMe based on reports of 5,798 people who have side effects when taking Kadcyla from the FDA, and is updated regularly.

What is Kadcyla?

Kadcyla has active ingredients of ado-trastuzumab emtansine. eHealthMe is studying from 5,813 Kadcyla users. Check the latest studies of Kadcyla.

What is Eczema exacerbated?

Eczema exacerbated is found to be associated with 1,253 drugs and 532 conditions by eHealthMe. Check the latest studies of Eczema exacerbated.

On Aug, 08, 2026

5,798 people reported to have side effects when taking Kadcyla.
Among them, 60 people (1.03%) have Eczema exacerbated.

Among these 60 people:

How long have people been on Kadcyla when they have Eczema exacerbated? *

What is the gender of people who have Eczema exacerbated when taking Kadcyla? *

female: 100 %
male: 0.0 %

What is the age of people who have Eczema exacerbated when taking Kadcyla? *

What are other drugs people take besides Kadcyla? *

Perjeta: 56 people, 93.33%
Taxol: 53 people, 88.33%
Benadryl: 53 people, 88.33%
Xeloda: 50 people, 83.33%
Solu-Medrol: 43 people, 71.67%
Magnesium: 43 people, 71.67%
Paclitaxel: 36 people, 60.00%
Tramadol Hydrochloride: 35 people, 58.33%
Herceptin: 22 people, 36.67%
Heparin: 18 people, 30.00%

What are other side effects people have besides Eczema exacerbated? *

Fatigue (feeling of tiredness): 60 people, 100.00%
Skin Fissures (a crack in the skin): 56 people, 93.33%
Nausea (feeling of having an urge to vomit): 55 people, 91.67%
Nasopharyngitis (inflammation of the nasopharynx): 54 people, 90.00%
Weight Decreased: 54 people, 90.00%
Itching: 54 people, 90.00%
Hypotension (abnormally low blood pressure): 54 people, 90.00%
Hepatitis (inflammation of the liver): 54 people, 90.00%
Headache (pain in head): 54 people, 90.00%
Malaise (a feeling of general discomfort or uneasiness): 54 people, 90.00%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 51 people, 85.00%
Pain: 41 people, 68.33%
Breast Cancer: 39 people, 65.00%
Skin Blushing/flushing (a sudden reddening of the face, neck): 18 people, 30.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 8.33%
Dyspnea (difficult or laboured breathing): 5 people, 8.33%
Cough: 5 people, 8.33%
Streptococcal Sepsis (whole body inflammation by streptococcal): 4 people, 6.67%
Skin Fissures (a crack in the skin): 4 people, 6.67%
Paronychia (infection in the tissues adjacent to a nail on a finger or toe): 4 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Kadcyla and have Eczema exacerbated?

- Check whether Eczema exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kadcyla:

Kadcyla (5,813 reports)

Browse all side effects of Kadcyla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eczema exacerbated:

Eczema exacerbated (1,253 drugs)

Browse all the conditions that are associated with Eczema exacerbated:

Eczema exacerbated (532 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ado-trastuzumab emtansine (the active ingredients of Kadcyla) and Kadcyla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.